Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleE6201, an intravenous MEK1 inhibitor, achieves an exceptional response in BRAF V600E-mutated metastatic malignant melanoma with brain metastases.AuthorsBabiker, Hani M.; Byron, Sara A.; Hendricks, William P. D.; Elmquist, William F.; Gampa, Gautham; Vondrak, Jessica; Aldrich, Jessica; Cuyugan, Lori; Adkins, Jonathan; De Luca, Valerie; Tibes, Raoul; Borad, Mitesh J.; Marceau, Katie; Myers, Thomas J.; Paradiso, Linda J.; Liang, Winnie S.; Korn, Ronald L.; Cridebring, Derek; Von Hoff, Daniel D.; Carpten, John D.PublicationInvestigational New Drugs, 2019, Vol 37, Issue 4, p636ISSN0167-6997Publication typeArticleDOI10.1007/s10637-018-0668-8